Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alps Alpine Co., Ltd. stock logo
APELY
Alps Alpine
$18.79
$19.00
$16.21
$23.50
$1.93B0.41,552 shs6 shs
DeNA Co., Ltd. stock logo
DNACF
DeNA
$17.46
$23.04
$9.23
$25.70
$1.94B0.01470 shsN/A
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
$4.66
$3.83
$3.15
$5.68
$493.78M1.0912,757 shsN/A
Shangri-La Asia Limited stock logo
SHALY
Shangri-La Asia
$10.76
$10.77
$10.75
$14.95
$1.93B-0.211,417 shsN/A
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alps Alpine Co., Ltd. stock logo
APELY
Alps Alpine
0.00%0.00%-2.64%-12.60%+1.57%
DeNA Co., Ltd. stock logo
DNACF
DeNA
0.00%-19.26%-28.92%-21.43%+85.39%
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
0.00%+18.68%+18.68%+12.02%+5.89%
Shangri-La Asia Limited stock logo
SHALY
Shangri-La Asia
0.00%0.00%0.00%-10.26%-29.21%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alps Alpine Co., Ltd. stock logo
APELY
Alps Alpine
2.9471 of 5 stars
0.05.02.50.02.00.81.9
DeNA Co., Ltd. stock logo
DNACF
DeNA
N/AN/AN/AN/AN/AN/AN/AN/A
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
N/AN/AN/AN/AN/AN/AN/AN/A
Shangri-La Asia Limited stock logo
SHALY
Shangri-La Asia
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alps Alpine Co., Ltd. stock logo
APELY
Alps Alpine
1.00
SellN/AN/A
DeNA Co., Ltd. stock logo
DNACF
DeNA
0.00
N/AN/AN/A
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
0.00
N/AN/AN/A
Shangri-La Asia Limited stock logo
SHALY
Shangri-La Asia
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest OXBDF, DNACF, APELY, and SHALY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/31/2025
Alps Alpine Co., Ltd. stock logo
APELY
Alps Alpine
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Strong Sell
(Data available from 6/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alps Alpine Co., Ltd. stock logo
APELY
Alps Alpine
$6.68B0.29$3.10 per share6.06$26.37 per share0.71
DeNA Co., Ltd. stock logo
DNACF
DeNA
$947.10M2.05$0.63 per share27.57$14.18 per share1.23
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
$111.34M4.43N/AN/A$1.01 per share4.61
Shangri-La Asia Limited stock logo
SHALY
Shangri-La Asia
$2.14B0.90$2.27 per share4.75$30.50 per share0.35
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alps Alpine Co., Ltd. stock logo
APELY
Alps Alpine
-$205.71M$2.42939.9717.080.320.02%1.73%0.93%7/30/2025 (Estimated)
DeNA Co., Ltd. stock logo
DNACF
DeNA
-$197.91M$1.4416.02N/A12.24%8.10%5.41%8/6/2025 (Estimated)
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
-$195.90MN/A0.00N/AN/AN/AN/AN/AN/A
Shangri-La Asia Limited stock logo
SHALY
Shangri-La Asia
$184.14MN/A0.00N/AN/AN/AN/A8/21/2025 (Estimated)

Latest OXBDF, DNACF, APELY, and SHALY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2025Q4 2025
DeNA Co., Ltd. stock logo
DNACF
DeNA
$0.1243$0.50+$0.3757$0.50$346.94 million$315.10 million
4/30/2025Q4 2025
Alps Alpine Co., Ltd. stock logo
APELY
Alps Alpine
$1.41-$0.16-$1.57$1.78$1.58 billion$1.75 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alps Alpine Co., Ltd. stock logo
APELY
Alps Alpine
$0.241.28%N/A9.92%N/A
DeNA Co., Ltd. stock logo
DNACF
DeNA
N/AN/AN/AN/AN/A
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
N/AN/AN/AN/AN/A
Shangri-La Asia Limited stock logo
SHALY
Shangri-La Asia
$0.514.74%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alps Alpine Co., Ltd. stock logo
APELY
Alps Alpine
0.14
2.01
1.31
DeNA Co., Ltd. stock logo
DNACF
DeNA
0.12
2.69
2.54
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
1.48
2.35
2.07
Shangri-La Asia Limited stock logo
SHALY
Shangri-La Asia
1.14
1.94
1.92

Institutional Ownership

CompanyInstitutional Ownership
Alps Alpine Co., Ltd. stock logo
APELY
Alps Alpine
0.10%
DeNA Co., Ltd. stock logo
DNACF
DeNA
N/A
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
N/A
Shangri-La Asia Limited stock logo
SHALY
Shangri-La Asia
N/A

Insider Ownership

CompanyInsider Ownership
Alps Alpine Co., Ltd. stock logo
APELY
Alps Alpine
10.40%
DeNA Co., Ltd. stock logo
DNACF
DeNA
N/A
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
N/A
Shangri-La Asia Limited stock logo
SHALY
Shangri-La Asia
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Alps Alpine Co., Ltd. stock logo
APELY
Alps Alpine
36,900102.79 million92.10 millionNot Optionable
DeNA Co., Ltd. stock logo
DNACF
DeNA
2,897111.35 millionN/ANot Optionable
Oxford Biomedica plc stock logo
OXBDF
Oxford Biomedica
891105.96 millionN/ANot Optionable
Shangri-La Asia Limited stock logo
SHALY
Shangri-La Asia
26,100179.28 millionN/ANot Optionable

Recent News About These Companies

Shangri-La unveils ‘Bandhan’, a luxury wedding service
SHALY Shangri-La Asia Limited
Ladakh: A Travelogue

New MarketBeat Followers Over Time

Media Sentiment Over Time

Alps Alpine stock logo

Alps Alpine OTCMKTS:APELY

$18.79 0.00 (0.00%)
As of 06/3/2025

Alps Alpine Co., Ltd. manufactures and sells electronic components in Japan and internationally. It operates through four segments: Components, Sensor Communication, Module Systems, and Logistics. The company's products for the consumer, industrial equipment, and IoT markets include TACT switches, worker condition monitoring systems, HAPTIC reactor, actuator for cameras, remote monitoring system for logistics, analog meter monitoring system, resistive position sensor, pressure sensor, air environment sensor module, three-axis geomagnetic sensor, humidity sensor, and pc board mount current sensor. Its products for the automotive market comprises TACT and detector switches, Encoder, aspherical glass lens with metal holder, HAPTIC reactor, trimagic converter, current sensor, magnetic sensor, millimeter-wave sensor, GNSS module, 5G NR module, power window switch, electric shifter, sound system, cabin controller, smart door trim, electric shifter, integrated display, premium sound speakers, and customized car products. The company also provides systems development, office, and financing and leasing services, as well as transportation, storage, and forwarding services. The company was formerly known as Alps Electric Co., Ltd. and changed its name to Alps Alpine Co., Ltd. in January 2019. The company was incorporated in 1948 and is headquartered in Tokyo, Japan.

DeNA stock logo

DeNA OTCMKTS:DNACF

$17.46 0.00 (0.00%)
As of 06/3/2025

DeNA Co., Ltd. develops and operates mobile and online services worldwide. It operates Mobage, an entertainment platform; Yahoo! Mobage, which offers social games for PC browsers; AndApp, a platform that allows users to play mobile game apps on PC browsers under the same user account; Pococha, a social live streaming community; and IRIAM, an app which allows to livestream as an anime character. The company also operates SHOWROOM, a virtual stage where fans can watch their artists perform live while interacting with them in real time; MYCODE, a direct-to-consumer genetic testing service; kencom, which supports health insurance societies to manage their members' health data; Haretoke, a web service which provides daily support for millennial women; Caradamo that offers diet support; and ONSEI, an app that uses AI to check for changes in cognitive function. In addition, it operates MENKYO, which enables cognitive function test for elderly drivers seeking license renewal; SHINRI-ADAS, a cognitive functional test; MRI-TAISEKI, a system that analyses brain DICOM images; Join, a communication app for medical professionals; MySOS, a life-saving and health support app with health and medical record for the user and their family; and DENA SPORTS GROUP, Yokohama DeNA Baystars, Kawasaki Brave Thunders, S.C.SAGAMIHARA, and DeNA Athletics Elite sports teams. Further, the company operates Mobaoku, which allows users to manage their auction items and bids from mobile phones; Anyca, a mobile app for peer-to-peer car sharing; SOMPO DE NORU, a car leasing service; GO, a taxi dispatch app; DRIVE CHART, an accident reduction support service; anone, a c ommunication service for seniors; dot-i, a security system; Coopel, a cloud robotic process automation service; PLAYBACK 9, a NFT service; Easy Ride, a robo-vehicle mobility service; Manga Box, a weekly manga magazine app; PICKFIVE, a NFT card game; and NFT collections. The company was incorporated in 1999 and is based in Tokyo, Japan.

Oxford Biomedica stock logo

Oxford Biomedica OTCMKTS:OXBDF

$4.66 0.00 (0.00%)
As of 06/3/2025

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, and adenoviral vectors. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.

Shangri-La Asia stock logo

Shangri-La Asia OTCMKTS:SHALY

$10.76 0.00 (0.00%)
As of 06/3/2025

Shangri-La Asia Limited, an investment holding company, develops, owns/leases, operates, and manages hotels and associated properties worldwide. It operates through Hotel Properties, Hotel Management and Related Services, Investment Properties, and Property Development for Sale segments. The company develops, owns, and operates office and commercial properties, and serviced apartments/residences; and operates restaurants and amusement parks. In addition, it is involved in the hotel ownership and management, and property rental and sale business; property investment; and develop and sale real estate, as well as retail and wines trading activities. The company operates hotels under the Shangri-La Hotels and Resorts, Kerry Hotels, JEN by Shangri-La, Traders Hotel, Rasa, Summer Palace, and Shang Palace, as well as CHI, The Spa at Shangri-La brand names. Shangri-La Asia Limited was founded in 1971 and is headquartered in Quarry Bay, Hong Kong.